MedTrace Logo

Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior

NCT00368290 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2018-03-15

Study results available
· View outcomes & findings →

Summary

The purpose of study is to determine if modafinil promotes cocaine abstinence and reduces high risk behavior in cocaine dependent subjects.

Conditions

  • Cocaine Dependence

Interventions

DRUG

Modafinil

300mg a day for 8 weeks

DRUG

placebo

placebo pills for 8 weeks

BEHAVIORAL

Cognitive Behavioral Therapy (CBT)

Weekly cognitive behavioral therapy sessions for a period of 8 weeks.

Sponsors & Collaborators

  • Kyle Kampman

    lead OTHER

Principal Investigators

  • Kyle M Kampman, M.D. · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2013-01-31
Completion
2013-01-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00368290 on ClinicalTrials.gov